CompletedPhase 2NCT03975153
Guselkumab in the Treatment of Pityriasis Rubra Pilaris (PRP)
Studying Pityriasis rubra pilaris
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Oregon Health and Science University
- Principal Investigator
- Teri Greiling, MD, PhDOregon Health and Science University
- Intervention
- guselkumab(biological)
- Enrollment
- 15 enrolled
- Eligibility
- 18-99 years · All sexes
- Timeline
- 2019 – 2024
Study locations (1)
- Oregon Health and Science University, Portland, Oregon, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03975153 on ClinicalTrials.govOther trials for Pityriasis rubra pilaris
Additional recruiting or active studies for the same condition.